腫瘤科
治療前病人評估和輸血風險評估
Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses. （開啟新視窗）
出處: J Surg Oncol 2015;112(5):496-502.
檢索: PubMed 26437866
DOI碼: 10.1002/jso.24029
Drug interactions with phytotherapeutics in oncology. （開啟新視窗）
出處: Expert Opin Drug Metab Toxicol 2014;10(3):359-77.
檢索: PubMed 24387348
DOI碼: 10.1517/17425255.2014.873786
Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation. （開啟新視窗）
出處: Transfusion 2012;52(9):2049-54.
檢索: PubMed 22321053
DOI碼: 10.1111/j.1537-2995.2011.03552.x
Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis. （開啟新視窗）
出處: Bone Marrow Transplant 2013;48(5):691-7.
檢索: PubMed 23085827
DOI碼: 10.1038/bmt.2012.194
Trends and risk factors for transfusion in hepatopancreatobiliary surgery. （開啟新視窗）
出處: J Gastrointest Surg 2014;18(4):719-28.
檢索: PubMed 24323432
DOI碼: 10.1007/s11605-013-2417-9
Potential interactions with anticancer agents: a cross-sectional study. （開啟新視窗）
出處: Chemotherapy 2013;59(2):85-92.
檢索: PubMed 23881290
DOI碼: 10.1159/000351133